Mangoceuticals, Inc.
MGRX
$1.73
$0.074.22%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.42M | -4.84M | -1.95M | -2.00M | -2.39M |
| Total Depreciation and Amortization | 836.20K | 415.00K | 721.80K | 300.00 | 32.50K |
| Total Amortization of Deferred Charges | -- | -- | -464.30K | 241.60K | 222.70K |
| Total Other Non-Cash Items | 3.23M | 1.99M | 507.20K | 611.50K | 877.40K |
| Change in Net Operating Assets | 97.10K | 160.20K | 54.10K | -20.00K | -318.80K |
| Cash from Operations | -1.26M | -2.27M | -1.13M | -1.17M | -1.58M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | 0.00 | 0.00 | 65.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 0.00 | 0.00 | 65.00K |
| Total Debt Issued | 600.00K | -- | -37.50K | 0.00 | 100.00K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.73M | 1.14M | 760.00K | 0.00 | 388.30K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | 1.15M | 400.00K | 750.00K | 1.50M |
| Repurchase of Preferred Stock | -1.05M | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.28M | 2.29M | 1.12M | 750.00K | 1.99M |
| Foreign Exchange rate Adjustments | 200.00 | 7.60K | -8.20K | -500.00 | -1.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 24.50K | 17.80K | -15.30K | -416.30K | 474.90K |